Logo image
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Journal article

Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer

Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, Hira Ghazal Shaikh, Alicia Beeghly-Fadiel, Benjamin French, Sachin R Jhawar, …
Cancer discovery, Vol.12(2), pp.303-330
02/01/2022
DOI: 10.1158/2159-8290.CD-21-1368
PMCID: PMC8831477
PMID: 34893494
url
https://www.ncbi.nlm.nih.gov/pmc/articles/8831477View
Open Access

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current or past history of cancer facing disparate consequences at every stage of the cancer trajectory. This comprehensive review offers a landscape analysis of the current state of the literature on COVID-19 and cancer, including the immune response to COVID-19, risk factors for severe disease, and impact of anticancer therapies. We also review the latest data on treatment of COVID-19 and vaccination safety and efficacy in patients with cancer, as well as the impact of the pandemic on cancer care, including the urgent need for rapid evidence generation and real-world study designs. SIGNIFICANCE: Patients with cancer have faced severe consequences at every stage of the cancer journey due to the COVID-19 pandemic. This comprehensive review offers a landscape analysis of the current state of the field regarding COVID-19 and cancer. We cover the immune response, risk factors for severe disease, and implications for vaccination in patients with cancer, as well as the impact of the COVID-19 pandemic on cancer care delivery. Overall, this review provides an in-depth summary of the key issues facing patients with cancer during this unprecedented health crisis.
COVID-19 - complications COVID-19 - epidemiology COVID-19 - therapy Humans Neoplasms - complications Neoplasms - immunology Neoplasms - therapy Pandemics

Details

Metrics

Logo image